Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

DAPTOMYCIN FOR INJECTION

ACCORD HEALTHCARE INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is DAPTOMYCIN FOR INJECTION discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that DAPTOMYCIN FOR INJECTION 500MG has been permanently discontinued (last updated October 24, 2023). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is DAPTOMYCIN FOR INJECTION not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file4 products
Affected strength500MG
Last updated2023-10-24

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

DAPTOMYCIN FOR INJECTION

TEVA CANADA LIMITED

500MG · DIN 02462117

Same strengthSame dosage formSame routeNo current shortage

CUBICIN

CUBIST PHARMACEUTICALS LLC

500MG · DIN 02299909

Same strengthSame dosage formSame routeNo current shortage

CUBICIN RF

CUBIST PHARMACEUTICALS LLC

500MG · DIN 02465493

Same strengthSame dosage formSame routeNo current shortage

DAPTOMYCIN FOR INJECTION RF

BAXTER CORPORATION

500MG · DIN 02518856

Same strengthSame dosage formSame routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02494590

Strength

500MG

Dosage Form

POWDER FOR SOLUTION

Route

INTRAVENOUS

Active Ingredient

DAPTOMYCIN

See all DAPTOMYCIN products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History